U.S., Sept. 10 -- An application to own the trademark for 'ELTIMZIC' has been filed on Jan. 31, 2025.
Owner(s):
Pfizer Inc.; 66 Hudson Boulevard East, , NEW YORK
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated derm...